What is NDC 83032-001?

83032-001 is the product NDC for Regadenoson, Regadenoson .08 mg/mL injection, solution, listed with the FDA by Indies Pharma Jamaica Limited. It has 1 package NDC, shown above in 10- and 11-digit form.

Indies Pharma Jamaica Limited, NDC labeler code 83032. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Regadenoson?

13 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Regadenoson NDC 83032-001 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)83032-001Labeler and product segments. Claims need a package NDC.

Product NDC at billing width83032-0001Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
83032-001-02	83032000102	1 SYRINGE in 1 CARTON (83032-001-02) / 5 mL in 1 SYRINGEMarketed from Aug 22, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Regadenoson
Generic name (nonproprietary): regadenoson
Active ingredients: Regadenoson — .08 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Indies Pharma Jamaica LimitedNDC labeler code 83032
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218054
Marketing start: Aug 22, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Adenosine Receptor Agonists (Mechanism)
Identifiers: Product ID 83032-001_46d9a23a-0b83-5f6f-e063-6394a90a8e79SPL ID 46d9a23a-0b83-5f6f-e063-6394a90a8e79SPL set ID 5095ab40-8503-46db-9b08-6a36f05fb5d9UNII 2XLN4Y044H
Pharmacologic class: Pharmacologic Cardiac Stress Test Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N483032000102 followed by a unit qualifier and the quantity

Package 83032-0001-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 26, 2025.

Indications (excerpt from the label)

Regadenoson Injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress. Regadenoson Injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 83032-001

What is NDC 83032-001?: 83032-001 is the product NDC for Regadenoson, Regadenoson .08 mg/mL injection, solution, listed with the FDA by Indies Pharma Jamaica Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Regadenoson.
What is the active ingredient?: Regadenoson.
Who is the labeler?: Indies Pharma Jamaica Limited, NDC labeler code 83032. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Regadenoson?: 13 other product NDCs are listed under this name. See all Regadenoson NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Regadenoson NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Regadenoson	Regadenoson .08 mg/mL	Injection, SolutionIntravenous	Apotex Corp.	60505-6288	60505-6288-00
Regadenoson	Regadenoson .08 mg/mL	Injection, SolutionIntravenous	Kanchan Healthcare Inc	85742-012	85742-0012-09
Regadenoson	Regadenoson .08 mg/mL	Injection, SolutionIntravenous	Marlex Pharmaceuticals, Inc.	10135-803	10135-0803-51
regadenoson	Regadenoson .08 mg/mL	Injection, SolutionIntravenous	Baxter Healthcare Corporation	36000-364	36000-0364-01
Regadenoson	Regadenoson anhydrous .08 mg/mL	InjectionIntravenous	Dr. Reddy's Laboratories Inc.	43598-616	43598-0616-11
Regadenoson	Regadenoson anhydrous .08 mg/mL	Injection, SolutionIntravenous	International Medication Systems, Limited	76329-3321	76329-3321-00
Regadenoson	Regadenoson anhydrous .08 mg/mL	Injection, SolutionIntravenous	Hikma Pharmaceuticals USA Inc.	0641-6253	00641-6253-01
Regadenoson	Regadenoson .08 mg/mL	Injection, SolutionIntravenous	Apotex Corp.	60505-6116	60505-6116-00
Regadenoson	Regadenoson .08 mg/mL	Injection, SolutionIntravenous	Accord Healthcare Inc.	16729-477	16729-0477-31
Regadenoson	Regadenoson anhydrous .08 mg/mL	Injection, SolutionIntravenous	Hospira, Inc.	0409-1401	00409-1401-01

All 14 Regadenoson NDCs

Other NDCs under ANDA 218054

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218054
Product	Strength	Form · route	Labeler	Product NDC
Regadenoson	Regadenoson .08 mg/mL	Injection, SolutionIntravenous	Kanchan Healthcare Inc	85742-012
Regadenoson	Regadenoson .08 mg/mL	Injection, SolutionIntravenous	Marlex Pharmaceuticals, Inc.	10135-803